Profitelligence Profitelligence · Filing Ledger Open DHR research →

Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-07-31

Stevens Raymond C Files Danaher (DHR) Form 4 - July 31, 2026

Stevens Raymond C bought 181 DHR shares worth $35.4K in this Form 4 filing, reported to the SEC on 2026-07-31.

Issuer
Danaher Corporation DHR · NYSE
Filed
Period
2026-07-31
Accession
0000313616-26-000165

Transactions (1)

Insider Date Type Shares Price Value Own
Stevens Raymond C 2026-07-31 Buy 181 $194.98 $35.4K Direct
Net change+181+$35.4K

About Danaher Corporation

Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Track DHR insider activity

Get alerted when Danaher Corporation executives buy or sell their shares.

Set up free alerts